Search results
Results from the WOW.Com Content Network
Nifedipine is considered safe in pregnancy and breastfeeding. [5] Nifedipine was patented in 1967, and approved for use in the United States in 1981. [2] [6] [7] It is on the World Health Organization's List of Essential Medicines. [8] It is available as a generic medication. [2]
Use in pregnancy may harm the baby and use when breastfeeding is not recommended. [1] It is an angiotensin II receptor blocker and works by blocking the effects of angiotensin II. [6] Telmisartan was patented in 1991 and came into medical use in 1999. [7] It is available as a generic medication. [8]
Breastfeeding and medications is the description of the medications that can be used by a breastfeeding mother, and the balance between maternal health and the safety of the breastfeeding infant. [1] [2] Medications, when administered to breastfeeding mothers, almost always are transferred to breast milk, albeit usually in small quantities. [3]
Several preparations containing olmesartan and other antihypertensives are available. Teva Pharmaceuticals produces a formulation containing olmesartan, amlodipine, and hydrochlorothiazide. [17] Benicar HCT is the brand name of a medication containing olmesartan medoxomil with hydrochlorothiazide. Benitec H, another medication containing ...
Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). [1] Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke , heart failure, kidney failure and myocardial infarction .
Antihypertensive agents comprise multiple classes of compounds that are intended to manage hypertension (high blood pressure). Antihypertensive therapy aims to maintain a blood pressure goal of <140/90 mmHg in all patients, as well as to prevent the progression or recurrence of cardiovascular diseases (CVD) in hypertensive patients with established CVD. [2]
Use appears safe in the latter part of pregnancy and it is not expected to cause problems during breastfeeding. [5] [6] It works by blocking the activation of β-and α-adrenergic receptors. [4] Labetalol was patented in 1966 and came into medical use in 1977. [7] It is available as a generic medication. [5]
Its use in pregnancy and breastfeeding is of unclear safety. [5] It is a non-selective beta blocker and works by blocking β1-adrenergic receptors in the heart and β2-adrenergic receptors in blood vessels. [2] Nadolol was patented in 1970 and came into medical use in 1978. [6] It is available as a generic medication. [2]